{
  "company_number": "06307519",
  "name": "Pharmland Ltd",
  "url": "/company/06307519",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2007-07-10",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "47730",
      "description": "Dispensing chemist in specialised stores",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/47730"
    }
  ],
  "registered_address": {
    "id": 1291557,
    "url": "/address/1291557",
    "line1": "JOSEPHS WELL SUITE 2C",
    "line2": "HANOVER WALK",
    "post_town": "LEEDS",
    "county": "WEST YORKSHIRE",
    "country": "UNITED KINGDOM",
    "postcode": "LS3 1AB"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06307519",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-04-30",
    "last_made_up": "2025-07-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/06307519/accounts/2025-07-31",
        "pdf_url": "/company/06307519/accounts/2025-07-31.pdf",
        "made_up_date": "2025-07-31",
        "period_start": "2025-07-31",
        "period_end": "2025-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": false,
        "average_employees": "18.00",
        "tangible_fixed_assets": "567935.00",
        "debtors": "332680.00",
        "cash_bank_in_hand": "188604.00",
        "current_assets": "630084.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "121834.00",
        "total_assets_less_current_liabilities": "689769.00",
        "net_assets_liabilities": "111912.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2026.zip"
      },
      {
        "url": "/company/06307519/accounts/2024-07-31",
        "pdf_url": "/company/06307519/accounts/2024-07-31.pdf",
        "made_up_date": "2024-07-31",
        "period_start": "2024-07-31",
        "period_end": "2024-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "16.00",
        "tangible_fixed_assets": "596681.00",
        "debtors": "342682.00",
        "cash_bank_in_hand": "195292.00",
        "current_assets": "639374.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "179179.00",
        "total_assets_less_current_liabilities": "775860.00",
        "net_assets_liabilities": "124532.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2025.zip"
      },
      {
        "url": "/company/06307519/accounts/2023-07-31",
        "pdf_url": "/company/06307519/accounts/2023-07-31.pdf",
        "made_up_date": "2023-07-31",
        "period_start": "2023-07-31",
        "period_end": "2023-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "16.00",
        "tangible_fixed_assets": "614780.00",
        "debtors": "345745.00",
        "cash_bank_in_hand": "129615.00",
        "current_assets": "567676.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-57289.00",
        "total_assets_less_current_liabilities": "557491.00",
        "net_assets_liabilities": "205706.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2024.zip"
      },
      {
        "url": "/company/06307519/accounts/2022-07-31",
        "pdf_url": "/company/06307519/accounts/2022-07-31.pdf",
        "made_up_date": "2022-07-31",
        "period_start": "2022-07-31",
        "period_end": "2022-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "15.00",
        "tangible_fixed_assets": "63401.00",
        "debtors": "232057.00",
        "cash_bank_in_hand": "266635.00",
        "current_assets": "559942.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "227084.00",
        "total_assets_less_current_liabilities": "290485.00",
        "net_assets_liabilities": "240011.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2023.zip"
      },
      {
        "url": "/company/06307519/accounts/2021-07-31",
        "pdf_url": "/company/06307519/accounts/2021-07-31.pdf",
        "made_up_date": "2021-07-31",
        "period_start": "2021-07-31",
        "period_end": "2021-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "14.00",
        "tangible_fixed_assets": "81072.00",
        "debtors": "338642.00",
        "cash_bank_in_hand": "327723.00",
        "current_assets": "719599.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "290481.00",
        "total_assets_less_current_liabilities": "371553.00",
        "net_assets_liabilities": "263061.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2022.zip"
      },
      {
        "url": "/company/06307519/accounts/2020-07-31",
        "pdf_url": "/company/06307519/accounts/2020-07-31.pdf",
        "made_up_date": "2020-07-31",
        "period_start": "2020-07-31",
        "period_end": "2020-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "15.00",
        "tangible_fixed_assets": "12868.00",
        "debtors": "272683.00",
        "cash_bank_in_hand": "280293.00",
        "current_assets": "601309.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "190831.00",
        "total_assets_less_current_liabilities": "203699.00",
        "net_assets_liabilities": "202052.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2021.zip"
      },
      {
        "url": "/company/06307519/accounts/2019-07-31",
        "pdf_url": "/company/06307519/accounts/2019-07-31.pdf",
        "made_up_date": "2019-07-31",
        "period_start": "2019-07-31",
        "period_end": "2019-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "13.00",
        "tangible_fixed_assets": "12303.00",
        "debtors": "336022.00",
        "cash_bank_in_hand": "24214.00",
        "current_assets": "402721.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "98367.00",
        "total_assets_less_current_liabilities": "110670.00",
        "net_assets_liabilities": "109308.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2020.zip"
      },
      {
        "url": "/company/06307519/accounts/2018-07-31",
        "pdf_url": "/company/06307519/accounts/2018-07-31.pdf",
        "made_up_date": "2018-07-31",
        "period_start": "2018-07-31",
        "period_end": "2018-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "13.00",
        "tangible_fixed_assets": "15123.00",
        "debtors": "331422.00",
        "cash_bank_in_hand": "46808.00",
        "current_assets": "416437.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "73165.00",
        "total_assets_less_current_liabilities": "88288.00",
        "net_assets_liabilities": "86714.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2019.zip"
      },
      {
        "url": "/company/06307519/accounts/2017-07-31",
        "pdf_url": "/company/06307519/accounts/2017-07-31.pdf",
        "made_up_date": "2017-07-31",
        "period_start": "2017-07-31",
        "period_end": "2017-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "11.00",
        "tangible_fixed_assets": "16211.00",
        "debtors": "329548.00",
        "cash_bank_in_hand": "4856.00",
        "current_assets": "370204.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "29571.00",
        "total_assets_less_current_liabilities": "45782.00",
        "net_assets_liabilities": "44289.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2018.zip"
      },
      {
        "url": "/company/06307519/accounts/2016-07-31",
        "pdf_url": "/company/06307519/accounts/2016-07-31.pdf",
        "made_up_date": "2016-07-31",
        "period_start": "2016-07-31",
        "period_end": "2016-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": "12.00",
        "tangible_fixed_assets": "6419.00",
        "debtors": "297789.00",
        "cash_bank_in_hand": "40384.00",
        "current_assets": "369473.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "54218.00",
        "total_assets_less_current_liabilities": "60637.00",
        "net_assets_liabilities": "59353.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2017.zip"
      },
      {
        "url": "/company/06307519/accounts/2015-07-31",
        "pdf_url": "/company/06307519/accounts/2015-07-31.pdf",
        "made_up_date": "2015-07-31",
        "period_start": "2015-07-31",
        "period_end": "2015-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "6100.00",
        "debtors": "205869.00",
        "cash_bank_in_hand": "159705.00",
        "current_assets": "395177.00",
        "creditors_due_within_one_year": "346694.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "48483.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "54583.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "53583.00",
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2016.zip"
      },
      {
        "url": "/company/06307519/accounts/2014-07-31",
        "pdf_url": "/company/06307519/accounts/2014-07-31.pdf",
        "made_up_date": "2014-07-31",
        "period_start": "2014-07-31",
        "period_end": "2014-07-31",
        "entity_name": "Pharmland Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "8134.00",
        "debtors": "293379.00",
        "cash_bank_in_hand": "70757.00",
        "current_assets": "392348.00",
        "creditors_due_within_one_year": "313257.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "79091.00",
        "total_assets_less_current_liabilities": "87225.00",
        "net_assets_liabilities": "87225.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "86225.00",
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2015.zip"
      },
      {
        "url": "/company/06307519/accounts/2013-07-31",
        "pdf_url": "/company/06307519/accounts/2013-07-31.pdf",
        "made_up_date": "2013-07-31",
        "period_start": "2013-07-31",
        "period_end": "2013-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "11826.00",
        "debtors": "272142.00",
        "cash_bank_in_hand": "105626.00",
        "current_assets": "405091.00",
        "creditors_due_within_one_year": "226587.00",
        "creditors_due_after_one_year": "5680.00",
        "net_current_assets_liabilities": "178504.00",
        "total_assets_less_current_liabilities": "190330.00",
        "net_assets_liabilities": "108989.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "107989.00",
        "shareholder_funds": "108989.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2014.zip"
      },
      {
        "url": "/company/06307519/accounts/2012-07-31",
        "pdf_url": "/company/06307519/accounts/2012-07-31.pdf",
        "made_up_date": "2012-07-31",
        "period_start": "2012-07-31",
        "period_end": "2012-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "8235.00",
        "debtors": "179982.00",
        "cash_bank_in_hand": "74034.00",
        "current_assets": "279850.00",
        "creditors_due_within_one_year": "170423.00",
        "creditors_due_after_one_year": "9964.00",
        "net_current_assets_liabilities": "109427.00",
        "total_assets_less_current_liabilities": "117662.00",
        "net_assets_liabilities": "107698.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "106698.00",
        "shareholder_funds": "107698.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2013.zip"
      },
      {
        "url": "/company/06307519/accounts/2011-07-31",
        "pdf_url": "/company/06307519/accounts/2011-07-31.pdf",
        "made_up_date": "2011-07-31",
        "period_start": "2011-07-31",
        "period_end": "2011-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "8605.00",
        "debtors": "153598.00",
        "cash_bank_in_hand": "62734.00",
        "current_assets": "245233.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "70691.00",
        "total_assets_less_current_liabilities": "79296.00",
        "net_assets_liabilities": "64881.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "63881.00",
        "shareholder_funds": "64881.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2012.zip"
      },
      {
        "url": "/company/06307519/accounts/2010-07-31",
        "pdf_url": "/company/06307519/accounts/2010-07-31.pdf",
        "made_up_date": "2010-07-31",
        "period_start": "2010-07-31",
        "period_end": "2010-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "7065.00",
        "debtors": "62663.00",
        "cash_bank_in_hand": "40980.00",
        "current_assets": "123323.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "31623.00",
        "total_assets_less_current_liabilities": "38688.00",
        "net_assets_liabilities": "20048.00",
        "called_up_share_capital": "1000.00",
        "profit_loss_account_reserve": "19048.00",
        "shareholder_funds": "20048.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2011.zip"
      },
      {
        "url": "/company/06307519/accounts/2009-07-31",
        "pdf_url": "/company/06307519/accounts/2009-07-31.pdf",
        "made_up_date": "2009-07-31",
        "period_start": "2009-07-31",
        "period_end": "2009-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1000.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1000.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2010.zip"
      },
      {
        "url": "/company/06307519/accounts/2008-07-31",
        "pdf_url": "/company/06307519/accounts/2008-07-31.pdf",
        "made_up_date": "2008-07-31",
        "period_start": "2008-07-31",
        "period_end": "2008-07-31",
        "entity_name": "Pharmland Ltd",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1000.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1000.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-JanuaryToDecember2009.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06307519/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-07-03",
    "last_made_up": "2026-06-19"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mrs Ella Chor Kei Holder",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/1436284",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2026-04-10",
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Pharmland Holdings Ltd",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": "/company/17127589",
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2026-04-10",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-29T20:59:03.591456+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}